Cargando…

NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer

Background: Non-alcoholic fatty liver disease (NAFLD) has gradually emerged as the most prevalent cause of chronic liver diseases. However, specific changes during the progression of NAFLD from non-fibrosis to advanced fibrosis and then hepatocellular carcinoma (HCC) are unresolved. Here, we firstly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Taofei, Chen, Guanglei, Qiao, Xinbo, Chen, Hui, Sun, Lisha, Ma, Qingtian, Li, Na, Wang, Junqi, Dai, Chaoliu, Xu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010788/ https://www.ncbi.nlm.nih.gov/pubmed/35431924 http://dx.doi.org/10.3389/fphar.2022.823140

Ejemplares similares

The CD112R/CD112 axis: a breakthrough in cancer immunotherapy
por: Zeng, Taofei, et al.
Publicado: (2021)

NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein
por: Guo, Hui, et al.
Publicado: (2021)

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD
por: Busca, C., et al.
Publicado: (2022)

Corrigendum: NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein
por: Guo, Hui, et al.
Publicado: (2021)

NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
por: Xia, Ming-Feng, et al.
Publicado: (2019)

Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis
por: Wang, Xinchen, et al.
Publicado: (2023)

NUSAP1 promotes invasion and metastasis of prostate cancer
por: Gordon, Catherine A., et al.
Publicado: (2017)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
por: Lei, Sisi, et al.
Publicado: (2022)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis
por: Liu, Linglong, et al.
Publicado: (2020)

NuSAP modulates the dynamics of kinetochore microtubules by attenuating MCAK depolymerisation activity
por: Li, Chenyu, et al.
Publicado: (2016)

Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction
por: Cao, Yuhan, et al.
Publicado: (2022)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
por: Qiao, Xinbo, et al.
Publicado: (2023)

O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness
por: Chen, Yifan, et al.
Publicado: (2021)

Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression
por: Zhang, Ling, et al.
Publicado: (2021)

Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2/HO-1 pathway
por: Pengnet, Sirinat, et al.
Publicado: (2022)

Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms
por: Cui, Yizhe, et al.
Publicado: (2019)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
por: Wang, Man, et al.
Publicado: (2022)

Nanoparticle-Encapsulated Liushenwan Could Treat Nanodiethylnitrosamine-Induced Liver Cancer in Mice by Interfering With Multiple Critical Factors for the Tumor Microenvironment
por: Hong, Jing, et al.
Publicado: (2020)

Analyzing Roles of NUSAP1 From Clinical, Molecular Mechanism and Immune Perspectives in Hepatocellular Carcinoma
por: Zhu, Wenjie, et al.
Publicado: (2021)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression
por: Wang, Yuying, et al.
Publicado: (2021)

Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer
por: Xie, Qiqi, et al.
Publicado: (2020)

MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer
por: Deng, Yajun, et al.
Publicado: (2020)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

The Protective Effects of Ivabradine in Preventing Progression from Viral Myocarditis to Dilated Cardiomyopathy
por: Yue-Chun, Li, et al.
Publicado: (2016)

Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD
por: Huang, Qian, et al.
Publicado: (2022)

Blockade of Autophagy Prevents the Development and Progression of Peritoneal Fibrosis
por: Shi, Yingfeng, et al.
Publicado: (2021)

Targeting Gremlin 1 Prevents Intestinal Fibrosis Progression by Inhibiting the Fatty Acid Oxidation of Fibroblast Cells
por: Yang, Yang, et al.
Publicado: (2021)

Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice
por: Li, Songtao, et al.
Publicado: (2020)

NUSAP1, a novel stemness‐related protein, promotes early recurrence of hepatocellular carcinoma
por: Li, Jinying, et al.
Publicado: (2022)

Isolation and Quantification of the Hepatoprotective Flavonoids From Scleromitron diffusum (Willd.) R. J. Wang With Bio-Enzymatic Method Against NAFLD by UPLC–MS/MS
por: Qin, Yuxi, et al.
Publicado: (2022)

Perforin Acts as an Immune Regulator to Prevent the Progression of NAFLD
por: Wang, Qian, et al.
Publicado: (2020)

Comparison of efficacy of anti-diabetics on non-diabetic NAFLD: A network meta-analysis
por: Jin, Dachuan, et al.
Publicado: (2023)

Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS/MS
por: Nie, Wenlong, et al.
Publicado: (2023)

NUSAP1 promotes the metastasis of breast cancer cells via the AMPK/PPARγ signaling pathway
por: Qiu, Juanjuan, et al.
Publicado: (2021)

Ganoderma lucidum Immune Modulator Protein rLZ-8 Could Prevent and Reverse Bone Loss in Glucocorticoids-Induced Osteoporosis Rat Model
por: Yang, Yong, et al.
Publicado: (2020)

Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway
por: Gao, Shun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p0csv5cdak5o6ts03ftq7fa2hv